HighTide, Profil Institute team-up against diabetes and NAFLD

HighTide, Profil Institute team-up against diabetes and NAFLD

HighTide, Profil Institute team-up against diabetes and NAFLD

August 1, 2016 – HighTide Biopharmaceutical and the Profil Institute announced a partnership focused on developing therapies for diabetes and nonalcoholic fatty liver disease, according to a press release.

Read the full article at Healio ยป